Cardiac Rhythm DisordersPSRNCT01524276
Product Surveillance Registry
An observational study of Cardiac Rhythm Disorders and Urological Disorders, run by Medtronic at 402 sites in 41 countries.
Trial summary
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders
- How many people
- 100,000 participants
- Where
- 402 sitesin 41 countries
- Study dates
- Jan 2012to Jan 2040
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Subjects implanted with Medtronic qualifying therapy product.
Who may be able to join
- Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- Patient has or is intended to receive or be treated with an eligible Medtronic product
- Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment
Who cannot join
- Patient who is, or will be, inaccessible for follow-up
- Patient with exclusion criteria required by local law
- Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Trial locations and contacts
402 sites in 41 countries. Contact the study team or a site near you to ask about taking part.
Medtronic Product Surveillance Registry contact
402 sites in 41 countries
United States136 sites, 130 recruiting
- Recruiting
Study site
Albany, New York
- Recruiting
Study site
Albuquerque, New Mexico
- Recruiting
Study site
Aliso Viejo, California
- Recruiting
Study site
Allentown, Pennsylvania
- Recruiting
Study site
Ann Arbor, Michigan
- Recruiting
Study site
Aurora, Colorado
- Recruiting
Study site
Austin, Texas
- Recruiting
Study site
Bay City, Michigan
- Recruiting
Study site
Bay Shore, New York
- Recruiting
Study site
Bethlehem, Pennsylvania
- Recruiting
Study site
Birmingham, Alabama
- Recruiting
Study site
Boston, Massachusetts
- Recruiting
Study site
Bradenton, Florida
- Recruiting
Study site
Bremerton, Washington
- Recruiting
Study site
Burlington, Vermont
- Recruiting
Study site
Camden, New Jersey
- Recruiting
Study site
Chandler, Arizona
- Recruiting
Study site
Chapel Hill, North Carolina
- Recruiting
Study site
Charleston, North Carolina
- Recruiting
Study site
Charleston, South Carolina
- Recruiting
Study site
Charlottesville, Virginia
- Recruiting
Study site
Chicago, Illinois
- Recruiting
Study site
Chula Vista, California
- Recruiting
Study site
Clearwater, Florida
- Recruiting
Study site
Cleveland, Ohio
- Recruiting
Study site
Colorado Springs, Colorado
- Recruiting
Study site
Colton, California
- Recruiting
Study site
Columbia, Missouri
- Recruiting
Study site
Columbia, South Carolina
- Recruiting
Study site
Columbus, Ohio
- Recruiting
Study site
Coon Rapids, Minnesota
- Recruiting
Study site
Dallas, Texas
- Recruiting
Study site
Danville, Pennsylvania
- Recruiting
Study site
Darien, Connecticut
- Recruiting
Study site
Davie, Florida
- Recruiting
Study site
Dayton, Ohio
- Recruiting
Study site
Durham, North Carolina
- Recruiting
Study site
Edenton, North Carolina
- Recruiting
Study site
Edgewood, Kentucky
- Recruiting
Study site
Erie, Pennsylvania
- Recruiting
Study site
Evansville, Indiana
- Recruiting
Study site
Fairfax, Virginia
- Recruiting
Study site
Falls Church, Virginia
- Recruiting
Study site
Fort Worth, Texas
- Recruiting
Study site
Fredericksburg, Virginia
- Active, not recruiting
Study site
Gainesville, Georgia
- Recruiting
Study site
Germantown, Tennessee
- Recruiting
Study site
Grapevine, Texas
- Recruiting
Study site
Hartford, Connecticut
- Recruiting
Study site
Holyoke, Massachusetts
- Recruiting
Study site
Houston, Texas
- Recruiting
Study site
Huntington, New York
- Recruiting
Study site
Huntsville, Alabama
- Recruiting
Study site
Hyattsville, Maryland
- Recruiting
Study site
Indianapolis, Indiana
- Recruiting
Study site
Iowa City, Iowa
- Active, not recruiting
Study site
Jackson, Mississippi
- Recruiting
Study site
Jacksonville, Florida
- Recruiting
Study site
Kansas City, Kansas
- Recruiting
Study site
Kansas City, Missouri
- Recruiting
Study site
Kyle, Texas
- Recruiting
Study site
La Jolla, California
- Recruiting
Study site
Lakewood, Colorado
- Recruiting
Study site
Lancaster, Pennsylvania
- Recruiting
Study site
Lansing, Michigan
- Active, not recruiting
Study site
Lebanon, New Hampshire
- Recruiting
Study site
Little Rock, Arkansas
- Recruiting
Study site
Los Angeles, California
- Recruiting
Study site
Louisville, Kentucky
- Recruiting
Study site
Madison, Wisconsin
- Recruiting
Study site
Manhasset, New York
- Recruiting
Study site
Marlton, New Jersey
- Recruiting
Study site
Mechanicsburg, Pennsylvania
- Recruiting
Study site
Memphis, Tennessee
- Recruiting
Study site
Minneapolis, Minnesota
- Recruiting
Study site
Morgantown, West Virginia
- Recruiting
Study site
Morristown, New Jersey
- Recruiting
Study site
Mount Kisco, New York
- Recruiting
Study site
Mount Orab, Ohio
- Recruiting
Study site
Napa, California
- Recruiting
Study site
Naples, Florida
- Recruiting
Study site
Nashville, Tennessee
- Recruiting
Study site
New Haven, Connecticut
- Recruiting
Study site
New Hyde Park, New York
- Recruiting
Study site
New Orleans, Louisiana
- Recruiting
Study site
New York, New York
- Recruiting
Study site
Ocean Township, New Jersey
- Recruiting
Study site
Omaha, Nebraska
- Recruiting
Study site
Orangeburg, South Carolina
- Recruiting
Study site
Panama City, Florida
- Recruiting
Study site
Philadelphia, Pennsylvania
- Recruiting
Study site
Phoenix, Arizona
- Recruiting
Study site
Pinehurst, North Carolina
- Recruiting
Study site
Pittsburgh, Pennsylvania
- Recruiting
Study site
Plano, Texas
- Recruiting
Study site
Port Jefferson, New York
- Recruiting
Study site
Portland, Oregon
- Recruiting
Study site
Poughkeepsie, New York
- Recruiting
Study site
Raleigh, North Carolina
- Recruiting
Study site
Redwood City, California
- Active, not recruiting
Study site
Reno, Nevada
- Recruiting
Study site
Riverhead, New York
- Recruiting
Study site
Robbinsdale, Minnesota
- Recruiting
Study site
Rochester, Minnesota
- Recruiting
Study site
Rochester Hills, Michigan
- Active, not recruiting
Study site
Roslyn, New York
- Recruiting
Study site
Safety Harbor, Florida
- Active, not recruiting
Study site
Saint Cloud, Minnesota
- Recruiting
Study site
Salinas, California
- Recruiting
Study site
Salisbury, Maryland
- Recruiting
Study site
Salt Lake City, Utah
- Recruiting
Study site
San Antonio, Texas
- Recruiting
Study site
San Diego, California
- Recruiting
Study site
Sarasota, Florida
- Recruiting
Study site
Seattle, Washington
- Recruiting
Study site
Sewickley, Pennsylvania
- Recruiting
Study site
Silver Spring, Maryland
- Recruiting
Study site
Sioux Falls, South Dakota
- Recruiting
Study site
Spartanburg, South Carolina
- Recruiting
Study site
Spokane, Washington
- Recruiting
Study site
St Louis, Missouri
- Recruiting
Study site
Stanford, California
- Recruiting
Study site
Staten Island, New York
- Recruiting
Study site
Stony Brook, New York
- Recruiting
Study site
Tampa, Florida
- Recruiting
Study site
Teaneck, New Jersey
- Recruiting
Study site
Temecula, California
- Recruiting
Study site
Torrance, California
- Recruiting
Study site
Tyler, Texas
- Recruiting
Study site
Utica, New York
- Recruiting
Study site
Ventura, California
- Recruiting
Study site
Washington D.C., District of Columbia
- Recruiting
Study site
West Des Moines, Iowa
- Recruiting
Study site
Weston, Florida
- Recruiting
Study site
Wilkes-Barre, Pennsylvania
- Recruiting
Study site
Ypsilanti, Michigan
Japan38 sites, 37 recruiting
- Recruiting
Study site
Ageo, Saitama
- Recruiting
Study site
Bunkyō-Ku, Tokyo
- Recruiting
Study site
Chiba
- Recruiting
Study site
Fukui
- Recruiting
Study site
Fukuoka
- Recruiting
Study site
Gifu
- Recruiting
Study site
Hamamatsu
- Recruiting
Study site
Hidaka, Saitama
- Recruiting
Study site
Hirosaki
- Recruiting
Study site
Hiroshima
- Recruiting
Study site
Kagoshima
- Recruiting
Study site
Kamakura
- Recruiting
Study site
Kawasaki
- Recruiting
Study site
Kitakyushu
- Recruiting
Study site
Kofu
- Recruiting
Study site
Koshigaya, Saitama
- Recruiting
Study site
Kumamoto
- Recruiting
Study site
Kyoto
- Recruiting
Study site
Minato-Ku, Tokyo
- Recruiting
Study site
Mitaka
- Recruiting
Study site
Nagoya
- Recruiting
Study site
Niigata
- Recruiting
Study site
Nishinomiya
- Recruiting
Study site
Okayama
- Recruiting
Study site
Osaka
- Recruiting
Study site
Ōsaka-sayama
- Recruiting
Study site
Ōta-ku
- Recruiting
Study site
Sakai, Osaka
- Recruiting
Study site
Sapporo
- Recruiting
Study site
Shinagawa-Ku
- Recruiting
Study site
Shizuoka
- Recruiting
Study site
Suita
- Recruiting
Study site
Tokyo, Tachikawa
- Active, not recruiting
Study site
Tokyo
- Recruiting
Study site
Toyoake
- Recruiting
Study site
Urasoe
- Recruiting
Study site
Yokohama
- Recruiting
Study site
Yonago, Tottori
France25 sites, 24 recruiting
- Recruiting
Study site
Avignon
- Recruiting
Study site
Bordeaux
- Recruiting
Study site
Boulogne-Billancourt
- Recruiting
Study site
Brest
- Recruiting
Study site
Caen
- Recruiting
Study site
Chambray
- Recruiting
Study site
Clermont-Ferrand
- Recruiting
Study site
Créteil
- Recruiting
Study site
Dijon
- Recruiting
Study site
La Rochelle
- Recruiting
Study site
La Tronche
- Recruiting
Study site
Lille
- Recruiting
Study site
Marseille
- Recruiting
Study site
Montpellier
- Recruiting
Study site
Nantes
- Active, not recruiting
Study site
Ollioules
- Recruiting
Study site
Paris
- Recruiting
Study site
Pessac
- Recruiting
Study site
Pringy
- Recruiting
Study site
Rennes
- Recruiting
Study site
Rouen
- Recruiting
Study site
Saint-Priest-en-Jarez
- Recruiting
Study site
Strasbourg
- Recruiting
Study site
Toulouse
- Recruiting
Study site
Villeurbanne
Germany25 sites, 23 recruiting
- Recruiting
Study site
Aachen
- Recruiting
Study site
Arnsberg
- Recruiting
Study site
Bad Oeynhausen
- Recruiting
Study site
Berlin
- Active, not recruiting
Study site
Berlin
- Recruiting
Study site
Bielefeld
- Recruiting
Study site
Bochum
- Recruiting
Study site
Bremen
- Recruiting
Study site
Cologne
- Recruiting
Study site
Düsseldorf
- Recruiting
Study site
Hagen
- Recruiting
Study site
Halle
- Recruiting
Study site
Hamburg
- Recruiting
Study site
Hanover
- Recruiting
Study site
Heidelberg
- Recruiting
Study site
Jena
- Recruiting
Study site
Karlsruhe
- Recruiting
Study site
Leipzig
- Recruiting
Study site
Lübeck
- Recruiting
Study site
München
- Terminated
Study site
Münster
- Recruiting
Study site
Stuttgart
- Recruiting
Study site
Tübingen
- Recruiting
Study site
Ulm
- Recruiting
Study site
Wiesbaden
Italy19 sites, 17 recruiting
- Recruiting
Study site
Acquaviva delle Fonti
- Recruiting
Study site
Ancona
- Recruiting
Study site
Bari
- Recruiting
Study site
Bergamo
- Recruiting
Study site
Bologna
- Recruiting
Study site
Brescia
- Recruiting
Study site
Caserta
- Recruiting
Study site
Castrovillari
- Active, not recruiting
Study site
Cotignola
- Recruiting
Study site
Lecce
- Recruiting
Study site
Milan
- Recruiting
Study site
Modena
- Recruiting
Study site
Monza
- Recruiting
Study site
Palermo
- Active, not recruiting
Study site
Pisa
- Recruiting
Study site
Roma
- Recruiting
Study site
Rome
- Recruiting
Study site
Taranto
- Recruiting
Study site
Udine
Spain16 sites, 15 recruiting
- Recruiting
Study site
A Coruña
- Recruiting
Study site
Córdoba
- Recruiting
Study site
Elche
- Recruiting
Study site
Girona
- Recruiting
Study site
Granada
- Recruiting
Study site
L'Hospitalet de Llobregat
- Recruiting
Study site
Madrid
- Recruiting
Study site
Málaga
- Recruiting
Study site
Palma de Mallorca
- Recruiting
Study site
Salamanca
- Recruiting
Study site
Santa Cruz de Tenerife
- Recruiting
Study site
Santiago de Compostela
- Recruiting
Study site
Toledo
- Recruiting
Study site
Valencia
- Recruiting
Study site
Valladolid
- Active, not recruiting
Study site
Vitoria-Gasteiz
United Kingdom16 sites, 13 recruiting
- Recruiting
Study site
Barnstaple
- Recruiting
Study site
Birmingham
- Recruiting
Study site
Blackpool
- Recruiting
Study site
Bristol
- Active, not recruiting
Study site
Chelmsford
- Active, not recruiting
Study site
Glasgow
- Recruiting
Study site
Harrow
- Recruiting
Study site
Leicester
- Recruiting
Study site
Liverpool
- Recruiting
Study site
London
- Recruiting
Study site
Manchester
- Recruiting
Study site
Middlesbrough
- Recruiting
Study site
Newcastle upon Tyne
- Terminated
Study site
Northampton
- Recruiting
Study site
Sheffield
- Recruiting
Study site
Southampton
China15 sites, 15 recruiting
- Recruiting
Study site
Beijing
- Recruiting
Study site
Chengdu, Sichuan
- Recruiting
Study site
Chengdu
- Recruiting
Study site
Dalian
- Recruiting
Study site
Guangzhou
- Recruiting
Study site
Hangzhou
- Recruiting
Study site
Harbin
- Recruiting
Study site
Hefei
- Recruiting
Study site
Kunming
- Recruiting
Study site
Nanchang
- Recruiting
Study site
Nanjing
- Recruiting
Study site
Nanning, Guangxi
- Recruiting
Study site
Shanghai
- Recruiting
Study site
Suzhou
- Recruiting
Study site
Ürümqi
South Korea14 sites, 14 recruiting
- Recruiting
Study site
Busan
- Recruiting
Study site
Changwon
- Recruiting
Study site
Cheongju-si
- Recruiting
Study site
Daegu
- Recruiting
Study site
Daejeon
- Recruiting
Study site
Gangneung
- Recruiting
Study site
Gwangju
- Recruiting
Study site
Gyeonggi-do
- Recruiting
Study site
Incheon
- Recruiting
Study site
Jeonju
- Recruiting
Study site
Seongnam-si
- Recruiting
Study site
Seoul
- Recruiting
Study site
Suwon
- Recruiting
Study site
Yangsan, Gyeongsangnam-do
Netherlands11 sites, 11 recruiting
- Recruiting
Study site
Amsterdam
- Recruiting
Study site
Doetinchem
- Recruiting
Study site
Eindhoven
- Recruiting
Study site
Enschede
- Recruiting
Study site
Groningen
- Recruiting
Study site
Hengelo
- Recruiting
Study site
Leiden
- Recruiting
Study site
Maastricht
- Recruiting
Study site
Nieuwegein
- Recruiting
Study site
Rotterdam
- Recruiting
Study site
The Hague
Belgium10 sites, 9 recruiting
- Recruiting
Study site
Aalst
- Recruiting
Study site
Bruges
- Recruiting
Study site
Brussels
- Recruiting
Study site
Edegem
- Active, not recruiting
Study site
Genk, Belgium
- Recruiting
Study site
Ghent
- Recruiting
Study site
Leuven
- Recruiting
Study site
Liège
- Recruiting
Study site
Roeselare
- Recruiting
Study site
Sint-Niklaas
Switzerland9 sites, 9 recruiting
- Recruiting
Study site
Basel
- Recruiting
Study site
Bern
- Recruiting
Study site
Fribourg
- Recruiting
Study site
Geneva
- Recruiting
Study site
Lausanne
- Recruiting
Study site
Lugano
- Recruiting
Study site
Meyrin
- Recruiting
Study site
Morges
- Recruiting
Study site
Zurich
India8 sites, 8 recruiting
- Recruiting
Study site
Bangalore
- Recruiting
Study site
Bengaluru
- Recruiting
Study site
Chennai
- Recruiting
Study site
Gūrgaon
- Recruiting
Study site
Hyderabad, Telangana
- Recruiting
Study site
Jaipur, Rajasthan
- Recruiting
Study site
Kochi
- Recruiting
Study site
New Delhi
Canada6 sites, 6 recruiting
- Recruiting
Study site
Calgary, Alberta
- Recruiting
Study site
Kingston, Ontario
- Recruiting
Study site
Montreal, Quebec
- Recruiting
Study site
Québec, Quebec
- Recruiting
Study site
Québec
- Recruiting
Study site
Toronto
Portugal5 sites, 5 recruiting
- Recruiting
Study site
Carnaxide
- Recruiting
Study site
Creixomil
- Recruiting
Study site
Lisbon
- Recruiting
Study site
Porto
- Recruiting
Study site
Santarém
Australia4 sites, 4 recruiting
- Recruiting
Study site
Chermside
- Recruiting
Study site
Murdoch
- Recruiting
Study site
Southport
- Recruiting
Study site
Westmead, New South Wales
Colombia4 sites, 4 recruiting
- Recruiting
Study site
Cartagena
- Recruiting
Study site
Medellín
- Recruiting
Study site
Pereira
- Recruiting
Study site
Rionegro
Denmark4 sites, 4 recruiting
- Recruiting
Study site
Copenhagen
- Recruiting
Study site
Hellerup
- Recruiting
Study site
Hillerød
- Recruiting
Study site
Odense
Israel4 sites, 2 recruiting
- Active, not recruiting
Study site
Ashkelon
- Recruiting
Study site
Beersheba
- Terminated
Study site
Jerusalem
- Recruiting
Study site
Ramat Gan
Greece3 sites, 3 recruiting
- Recruiting
Study site
Athens
- Recruiting
Study site
Marousi
- Recruiting
Study site
Thessaloniki
Norway3 sites, 2 recruiting
- Recruiting
Study site
Bergen
- Active, not recruiting
Study site
Lorenskog
- Recruiting
Study site
Trondheim
Poland3 sites, 3 recruiting
- Recruiting
Study site
Poznan
- Recruiting
Study site
Warsaw
- Recruiting
Study site
Zabrze
Austria2 sites, 2 recruiting
- Recruiting
Study site
Innsbruck
- Recruiting
Study site
Linz
Finland2 sites, 2 recruiting
- Recruiting
Study site
Helsinki
- Recruiting
Study site
Tampere
Puerto Rico2 sites, 2 recruiting
- Recruiting
Study site
Aibonito
- Recruiting
Study site
Rio Piedras
Saudi Arabia2 sites, 1 recruiting
- Recruiting
Study site
Jeddah
- Terminated
Study site
Riyadh
Sweden2 sites, 2 recruiting
- Recruiting
Study site
Gothenburg
- Recruiting
Study site
Lund
About this study
Official title: Medtronic Product Surveillance Registry
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
- Conditions
- Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders, Digestive Disorders, Intracranial Aneurysm
- Medical subject headings
- Urologic Diseases, Nervous System Diseases, Cardiovascular Diseases, Digestive System Diseases, Intracranial Aneurysm, Renal Insufficiency, Coronary Artery Disease
What is being measured
The primary outcome is the main question the study is designed to answer.
Safety and Effectiveness of Market Released products
Measured: Every 6-12 months (Therapy-dependent)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Feb 2012 (estimated)
- Study startJan 2012
- Primary completionJan 2040 (estimated)
- Study completionJan 2040 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for Cardiac Rhythm DisordersStudies of the same condition, open and under way.
- More trials run by MedtronicThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Medtronic
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01524276
- Sponsor's protocol ID
- PSR
- Acronym
- PSR
- Status last verified
- Dec 2025
- First submitted
- 30 Jan 2012
- Last updated
- 20 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Wu V, Makary MS, Tarter W, Elsaadany A, Shrestha P. Real-World Safety and Performance of Nylon and PGLA Fibered Detachable Coils in Peripheral Embolization: A Prospective Multicenter Registry. J Vasc Interv Radiol. 2026 Jul 14:108959. doi: 10.1016/j.jvir.2026.108959. Online ahead of print.
PubMed 42448174Quyn A, Navarro A, Caldonazo T, Findlay JM, Doenst T, Anderson M, Gong X, Botman JMJ. Real-World Performance of the Veriset Hemostatic Patch: A Multicenter Study of Adjunctive Hemostasis. Med Devices (Auckl). 2026 May 29;19:595863. doi: 10.2147/MDER.S595863. eCollection 2026.
PubMed 42239929Goya M, Park SJ, Ando K, Holbrook R, Iskandar R, Jacobsen L, Mozingo JD, Joung B; SPARK Registry Investigators. Safety and efficacy of an intrinsic antitachycardia pacing algorithm in patients from Japan and South Korea: results from a cardiac device registry in the Asia Pacific region. J Med Econ. 2025 Dec;28(1):1307-1318. doi: 10.1080/13696998.2025.2543213. Epub 2025 Aug 13.
PubMed 40758483Patel D, Rao A, Friedman PA, Deshmukh AJ, Lande J, Murphy JA, Brown ML, Lexcen DR, Wilkoff BL. New atrial arrhythmia occurrence in single chamber implantable cardioverter defibrillator patients: A real-world investigation. J Cardiovasc Electrophysiol. 2023 Feb;34(2):438-444. doi: 10.1111/jce.15790. Epub 2022 Dec 30.
PubMed 36579406Qin D, Filippaios A, Murphy J, Berg M, Lampert R, Schloss EJ, Noone M, Mela T. Short- and Long-Term Risk of Lead Dislodgement Events: Real-World Experience From Product Surveillance Registry. Circ Arrhythm Electrophysiol. 2022 Aug;15(8):e011029. doi: 10.1161/CIRCEP.122.011029. Epub 2022 Aug 4.
PubMed 35925831Garg A, Koneru JN, Fagan DH, Stromberg K, Padala SK, El-Chami MF, Roberts PR, Piccini JP, Cheng A, Ellenbogen KA. Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker. Heart Rhythm. 2020 Dec;17(12):2056-2063. doi: 10.1016/j.hrthm.2020.07.035. Epub 2020 Aug 4.
PubMed 32763431Singh JP, Cha YM, Lunati M, Chung ES, Li S, Smeets P, O'Donnell D. Real-world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes: Effect on mortality and atrial fibrillation incidence. J Cardiovasc Electrophysiol. 2020 Apr;31(4):825-833. doi: 10.1111/jce.14376. Epub 2020 Feb 28.
PubMed 32009263Stearns LM, Abd-Elsayed A, Perruchoud C, Spencer R, Hammond K, Stromberg K, Weaver T. Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry. Anesth Analg. 2020 Feb;130(2):289-297. doi: 10.1213/ANE.0000000000004425.
PubMed 31567325
Study at a glance
From the registry record, last updated by the sponsor on 20 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Medtronic Product Surveillance Registry
- ClinicalTrials.gov ID
- NCT01524276
- Acronym / sponsor ID
- PSR / PSR
- Conditions
- Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders, Digestive Disorders, Intracranial Aneurysm
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100,000 participants (estimated)
- Lead sponsor
- MedtronicIndustry (pharma, biotech, devices)
- Study start
- Jan 2012
- Primary completion
- Jan 2040 (estimated)
- Study completion
- Jan 2040 (estimated)
- First posted
- 1 Feb 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Subjects implanted with Medtronic qualifying therapy product.
Key inclusion criteria (3 listed)
- Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- Patient has or is intended to receive or be treated with an eligible Medtronic product
- Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment
Key exclusion criteria (3 listed)
- Patient who is, or will be, inaccessible for follow-up
- Patient with exclusion criteria required by local law
- Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Safety and Effectiveness of Market Released products
Time frame: Every 6-12 months (Therapy-dependent)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Oct 2026.
- Derived from this study: PubMed 42448174Wu V, Makary MS, Tarter W, Elsaadany A, Shrestha P. Real-World Safety and Performance of Nylon and PGLA Fibered Detachable Coils in Peripheral Embolization: A Prospective Multicenter Registry. J Vasc Interv Radiol. 2026 Jul 14:108959. doi: 10.1016/j.jvir.2026.108959. Online ahead of print.
- Derived from this study: PubMed 42239929Quyn A, Navarro A, Caldonazo T, Findlay JM, Doenst T, Anderson M, Gong X, Botman JMJ. Real-World Performance of the Veriset Hemostatic Patch: A Multicenter Study of Adjunctive Hemostasis. Med Devices (Auckl). 2026 May 29;19:595863. doi: 10.2147/MDER.S595863. eCollection 2026.
- Derived from this study: PubMed 40758483Goya M, Park SJ, Ando K, Holbrook R, Iskandar R, Jacobsen L, Mozingo JD, Joung B; SPARK Registry Investigators. Safety and efficacy of an intrinsic antitachycardia pacing algorithm in patients from Japan and South Korea: results from a cardiac device registry in the Asia Pacific region. J Med Econ. 2025 Dec;28(1):1307-1318. doi: 10.1080/13696998.2025.2543213. Epub 2025 Aug 13.
- Derived from this study: PubMed 36579406Patel D, Rao A, Friedman PA, Deshmukh AJ, Lande J, Murphy JA, Brown ML, Lexcen DR, Wilkoff BL. New atrial arrhythmia occurrence in single chamber implantable cardioverter defibrillator patients: A real-world investigation. J Cardiovasc Electrophysiol. 2023 Feb;34(2):438-444. doi: 10.1111/jce.15790. Epub 2022 Dec 30.
- Derived from this study: PubMed 35925831Qin D, Filippaios A, Murphy J, Berg M, Lampert R, Schloss EJ, Noone M, Mela T. Short- and Long-Term Risk of Lead Dislodgement Events: Real-World Experience From Product Surveillance Registry. Circ Arrhythm Electrophysiol. 2022 Aug;15(8):e011029. doi: 10.1161/CIRCEP.122.011029. Epub 2022 Aug 4.
- Derived from this study: PubMed 32763431Garg A, Koneru JN, Fagan DH, Stromberg K, Padala SK, El-Chami MF, Roberts PR, Piccini JP, Cheng A, Ellenbogen KA. Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker. Heart Rhythm. 2020 Dec;17(12):2056-2063. doi: 10.1016/j.hrthm.2020.07.035. Epub 2020 Aug 4.
- Derived from this study: PubMed 32009263Singh JP, Cha YM, Lunati M, Chung ES, Li S, Smeets P, O'Donnell D. Real-world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes: Effect on mortality and atrial fibrillation incidence. J Cardiovasc Electrophysiol. 2020 Apr;31(4):825-833. doi: 10.1111/jce.14376. Epub 2020 Feb 28.
- Derived from this study: PubMed 31567325Stearns LM, Abd-Elsayed A, Perruchoud C, Spencer R, Hammond K, Stromberg K, Weaver T. Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry. Anesth Analg. 2020 Feb;130(2):289-297. doi: 10.1213/ANE.0000000000004425.
- Individual participant dataSharing planned: No
Related trials for Cardiac Rhythm Disorders
Recruiting
Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration
Atrial Fibrillation (AF), Paroxysmal AF
RecruitingPhase 4
Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation
Atrial Fibrillation (AF), Coronary Artery Disease
Recruiting
Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication
Atrial Fibrillation (AF), Heart Failure With Mildly Reduced Ejection Fraction
Enrolling by invitationObservational study
Digital Phenotypes for Predicting Depression_Validation
Major Depressive Disorder, Bipolar I Disorder
Active, not recruitingObservational study
AVEIR DR Coverage With Evidence Development (CED) Study
Cardiac Pacemaker, Arrythmia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Medtronic Product Surveillance Registry contact
402 sites in 41 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiac Rhythm Disorders and Urological Disorders, run by Medtronic at 402 sites in 41 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 402 sites in United States, Japan, France, Germany, Italy and 36 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Medtronic Product Surveillance Registry (rs.productsurveillanceregistry@medtronic.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Safety and Effectiveness of Market Released products (time frame: Every 6-12 months (Therapy-dependent)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01524276, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026.